Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study

There are limited real-world data on the use of botulinum toxin type A (BoNT-A) in patients with multiple sclerosis (MS). Accordingly, this nationwide, population-based, retrospective cohort study aimed to describe BoNT-A treatment trends in patients with MS between 2014 and 2020 in France. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bensmail, Djamel, Karam, Pierre, Forestier, Anne, Loze, Jean-Yves, Lévy, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142089/
https://www.ncbi.nlm.nih.gov/pubmed/37104218
http://dx.doi.org/10.3390/toxins15040280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142089/
https://www.ncbi.nlm.nih.gov/pubmed/37104218
http://dx.doi.org/10.3390/toxins15040280

Ejemplares similares